Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
26.75
+0.35 (1.31%)
Nov 21, 2024, 1:59 PM EST - Market open

Celldex Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
9.986.882.364.657.423.57
Upgrade
Revenue Growth (YoY)
128.55%192.02%-49.32%-37.30%107.61%-62.54%
Upgrade
Cost of Revenue
147.04118.0182.2653.3142.5342.67
Upgrade
Gross Profit
-137.06-111.13-79.9-48.66-35.12-39.1
Upgrade
Selling, General & Admin
37.1230.9127.220.4914.4615.43
Upgrade
Operating Expenses
37.1230.9127.220.4914.4615.43
Upgrade
Operating Income
-174.18-142.04-107.1-69.15-49.57-54.53
Upgrade
Interest & Investment Income
32.613.112.910.512.414.15
Upgrade
EBT Excluding Unusual Items
-141.58-128.93-104.19-68.64-47.17-50.37
Upgrade
Gain (Loss) on Sale of Investments
------1.8
Upgrade
Legal Settlements
-12.5-12.5-15---
Upgrade
Other Unusual Items
--6.861.414.221.29
Upgrade
Pretax Income
-154.08-141.43-112.33-70.74-60.95-50.88
Upgrade
Income Tax Expense
----0.23-1.17-
Upgrade
Net Income
-154.08-141.43-112.33-70.51-59.78-50.88
Upgrade
Net Income to Common
-154.08-141.43-112.33-70.51-59.78-50.88
Upgrade
Shares Outstanding (Basic)
614847433015
Upgrade
Shares Outstanding (Diluted)
614847433015
Upgrade
Shares Change (YoY)
28.81%3.33%9.37%44.64%104.32%38.93%
Upgrade
EPS (Basic)
-2.53-2.92-2.40-1.64-2.02-3.51
Upgrade
EPS (Diluted)
-2.53-2.92-2.40-1.64-2.02-3.51
Upgrade
Free Cash Flow
-159.66-109.11-105.56-62.16-41.96-47.15
Upgrade
Free Cash Flow Per Share
-2.63-2.25-2.25-1.45-1.42-3.25
Upgrade
Operating Margin
-1745.97%-2063.66%-4543.74%-1486.73%-668.27%-1526.03%
Upgrade
Profit Margin
-1544.48%-2054.76%-4765.59%-1516.04%-805.88%-1423.96%
Upgrade
Free Cash Flow Margin
-1600.48%-1585.20%-4478.57%-1336.44%-565.60%-1319.51%
Upgrade
EBITDA
-171.06-139.03-104.2-66.08-45.64-49.67
Upgrade
D&A For EBITDA
3.123.012.93.073.934.86
Upgrade
EBIT
-174.18-142.04-107.1-69.15-49.57-54.53
Upgrade
Revenue as Reported
9.986.882.364.657.423.57
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.